1 - Title Slide 2 - Disclosures 3 - Definition 4 - Scope 5 - Normal, Moderate, Severe 6 - Vertebral Compression Fractures 7 - Hip Fractures 8 - Bone Health Physiology 9 - Bone Physiology 10 - Screening and Guidelines 11 - Osteoporotic Fracture Risk 12 - Evaluation 13 - Thyroid and Bone 14 - Thyroid Effects 15 - Hyperthyroidism 16 - Markers 17 - Markers (Cont.) 18 - Prevention 19 - Treatment 20 - Calcium and Vitamin D 21 - Anti-Resorptive & Anabolic 22 - Postmenopausal Treatment 23 - Bisphosphonates 24 - Continuous Increases 25 - Zoledronic Acid 26 - Zoledronic Acid (Cont.) 27 - Denosumab 28 - FREEDOM Trial 29 - Anabolic Therapy 30 - Teriparatide versus Oral Bisphos 31 - Anti-Sclerostin Antibody 32 - DXA Data 33 - Romosozumab 34 - Exercise and Osteoporosis 35 - Monitoring and follow up 36 - Case 1 37 - DXA Results 38 - Secondary Causes 39 - Secondary Evaluation 40 - Case 1 Management 41 - Case 2 42 - Osteoporosis in Men 43 - Case 2 (cont.) 44 - Bisphosphonate Holiday 45 - Summary 46 - Question: Vitamin K